Groupon deals on healthcare such as chest CT or lung, heart and full-body scans are popping up across Atlanta, as well as in Oklahoma and California. Groupon also offers discount coupons for expectant parents looking for ultrasounds, sold as “fetal memories.”
New startup aims to help investors avoid debacles through medical diligence
If they hope to grab a piece of the health-spending pie, investors and entrepreneurs may […]
Cigna creates new program to pay for high-price gene therapies
The payer unveiled Embarc Benefit Protection, which it said would enable plans to pay a monthly, per-member fee to enroll, while patients would not have to pay anything out of pocket.
Verily and iRhythm join forces to detect silent atrial fibrillation
Verily is being paid by iRhythm Technologies to develop a tool by improving existing hardware and software to effectively diagnose patients with asymptomatic atrial fibrillation.
Sumitomo pays $3B to Vivek Ramaswamy’s Roivant under new alliance
The Sumitomo Dainippon-Roivant Alliance will be wholly owned by Sumitomo, which is also taking control of five companies – and potentially six more – from Ramaswamy’s Vant family of firms.
Insurance premiums for Washington’s individual market are rising less than 1 percent on average next year, and the state’s insurance commissioner credits much of that moderation to homegrown insurance companies.
In part 2 of an executive interview series, CEO and physician Wyatt Decker discusses health care reinvention including technology, the human impact and physician burn-out.
Shares of Alexion fell more than 11 percent Friday as the office instituted an inter partes review for the drug, Soliris, in the blood disorder paroxysmal nocturnal hemoglobinuria.
The decision was a loss for Amgen, which had claimed that Sanofi and Regeneron’s drug Praluent infringed on its patents for the drug Repatha.
MedCity Influencers, Health Tech
As application functionalities and user bases evolve throughout the future, what remains certain, plain and simple, is that these apps will continue to help people save money on healthcare and health services.
In a guidance issued Wednesday, the agency said randomized, controlled trials of cancer drugs should only use placebo in cases like when surveillance is standard of care. A bioethics expert said such principles have long existed, but it was good to see them in an official guidance.
MedCity INVEST Digital Health, held September 17, 2019 in Minneapolis, will unite active investors with corporate business development executives to facilitate investment opportunities with the most innovative companies from the Digital Health sector. Reserve your place.>>
Health Services, Medical Education
With tens of thousands of American lives lost each year to drug overdose, it’s critical that we begin training Americans to administer Narcan (naloxone), just as we did with CPR, to help save the lives of our neighbors, family members and friends.
The agency warned against use of AbbVie’s Mavyret, Gilead Sciences’ Vesovi and Merck’s Zepatier in patients with moderate to severe liver disease amid reports of 63 patients with liver decompensation, with some cases being fatal.
Celgene will have opt-in rights to take responsibility for development, manufacturing and commercialization of T-cell receptor therapies that Immatics develops using its in-house technology.
American pharma companies — architects of the opioid crisis in the United States and avid hunters of new markets — stand at the ready to feed and fuel demand for painkillers in India where attitudes toward pain toleration have changed.
Promoted
In order to meet the needs of patients, healthcare providers will need to promote cultural competency.
Citing anonymous sources familiar with the matter, news outlets reported that the family would pay $3 billion toward a proposed $10-12 billion settlement to resolve the more than 2,000 lawsuits.
Avoiding gender bias in healthcare can be difficult both for healthcare providers and for the patients at risk of being harmed by it.
As providers look for ways to better engage with patients and improve outcomes, investors see potential in companies that are rewriting the rules of effective provider-patient communications.
The Alliance for Regenerative Medicine and 13 biotech companies released a statement outlining bioethical principles on genome editing, including opposition to modifications that can be passed to future generations.
Financial terms of the deal were not disclosed. However, Thread said it would use the investment – from JLL Partners and Water Street Healthcare Partners – to accelerate the expansion of its service offering globally.
One of the most time consuming tasks for payers is verifying data. One health tech company has developed a set of tools to help health insurers speed up this laborious, costly task.
While higher than the amounts that Purdue and Teva had to pay, an analyst wrote that the judgment is lower than what the state attorney general had sought. J&J said it plans to appeal the decision.
Mark Schoenebaum, a widely respected sell-side equity research analyst who most recently worked with Evercore ISI, and FibroGen CEO Thomas Neff, died during the weekend.
The dialysis industry spent about $2.5 million in California on lobbying and campaign contributions in the first half of this year in its ongoing battle to thwart regulation
Bristol-Myers Squibb said Celgene would sell the drug, Otezla (apremilast), to Amgen. The pharmaceutical company had said it would seek a divestment of the drug to satisfy competition concerns from the agency.
